Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance

International Journal of Infectious Diseases

Volumn 15, Issue 12, 2011, Pages

  Racil, Zdenek ^a   Kocmanova, Iva ^a   Toskova, Martina ^a   Buresova, Lucie ^b   Weinbergerova, Barbora ^a   Lengerova, Martina ^a   Rolencova, Monika ^a   Winterova, Jana ^a   Hrncirova, Kristyna ^a   Volfova, Pavlina ^a   Skrickova, Jana ^a   Mayer, Jiri ^a,b  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

BAL; Galactomannan; Hematological malignancy; Invasive pulmonary aspergillosis

Indexed keywords

ANTIFUNGAL AGENT; GALACTOMANNAN;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; DIAGNOSTIC VALUE; FEMALE; HEMATOLOGIC DISEASE; HUMAN; LUNG ASPERGILLOSIS; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL AGENTS; ASPERGILLUS; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; COHORT STUDIES; FEMALE; HEMATOLOGIC DISEASES; HEMATOLOGIC NEOPLASMS; HUMANS; INVASIVE PULMONARY ASPERGILLOSIS; MALE; MANNANS; MIDDLE AGED; NEUTROPENIA; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 82455187908     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2011.09.011     Document Type: Article

References (41)

1. Pagano L., Caira M., Candoni A., Offidani M., Fianchi L., Martino B., et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 2006, 91:1068-1075.
2. Kontoyiannis D.P., Marr K.A., Park B.J., Alexander B.D., Anaissie E.J., Walsh T.J., et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 2010, 50:1091-1100.
3. Baddley J.W., Andes D.R., Marr K.A., Kontoyiannis D.P., Alexander B.D., Kauffman C.A., et al. Factors associated with mortality in transplant patients with invasive aspergillosis. Clin Infect Dis 2010, 50:1559-1567.
4. Cuenca-Estrella M., Bassetti M., Lass-Florl C., Racil Z., Richardson M., Rogers T.R. Detection and investigation of invasive mould disease. J Antimicrob Chemother 2011, 66(Suppl 1):i15-i24.
5. Leeflang M.M., Debets-Ossenkopp Y.J., Visser C.E., Scholten R.J., Hooft L., Bijlmer H.A., et al. Galactomannan detection for invasive aspergillosis in immunocompromised patients. Cochrane Database Syst Rev 2008, (4):CD007394.
6. Klont R.R., Mennink-Kersten M.A., Verweij P.E. Utility of Aspergillus antigen detection in specimens other than serum specimens. Clin Infect Dis 2004, 39:1467-1474.
7. Hope W.W., Kruhlak M.J., Lyman C.A., Petraitiene R., Petraitis V., Francesconi A., et al. Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: implications for antifungal therapy. J Infect Dis 2007, 195:455-466.
8. Francesconi A., Kasai M., Petraitiene R., Petraitis V., Kelaher A.M., Schaufele R., et al. Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis. J Clin Microbiol 2006, 44:2475-2480.
9. Guo Y.L., Chen Y.Q., Wang K., Qin S.M., Wu C., Kong J.L. Accuracy of BAL galactomannan in diagnosing invasive aspergillosis: a bivariate metaanalysis and systematic review. Chest 2010, 138:817-824.
10. Musher B., Fredricks D., Leisenring W., Balajee S.A., Smith C., Marr K.A. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J Clin Microbiol 2004, 42:5517-5522.
11. Husain S., Paterson D.L., Studer S.M., Crespo M., Pilewski J., Durkin M., et al. Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients. Transplantation 2007, 83:1330-1336.
12. Nguyen M.H., Jaber R., Leather H.L., Wingard J.R., Staley B., Wheat L.J., et al. Use of bronchoalveolar lavage to detect galactomannan for diagnosis of pulmonary aspergillosis among nonimmunocompromised hosts. J Clin Microbiol 2007, 45:2787-2792.
13. Clancy C.J., Jaber R.A., Leather H.L., Wingard J.R., Staley B., Wheat L.J., et al. Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients. J Clin Microbiol 2007, 45:1759-1765.
14. Husain S., Clancy C.J., Nguyen M.H., Swartzentruber S., Leather H., LeMonte A.M., et al. Performance characteristics of the Platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid. Clin Vaccine Immunol 2008, 15:1760-1763.
15. Khan Z.U., Ahmad S., Theyyathel A.M. Detection of Aspergillus fumigatus-specific DNA, (1-3)-beta-d-glucan and galactomannan in serum and bronchoalveolar lavage specimens of experimentally infected rats. Mycoses 2008, 51:129-135.
16. Meersseman W., Lagrou K., Maertens J., Wilmer A., Hermans G., Vanderschueren S., et al. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med 2008, 177:27-34.
17. Desai R., Ross L.A., Hoffman J.A. The role of bronchoalveolar lavage galactomannan in the diagnosis of pediatric invasive aspergillosis. Pediatr Infect Dis J 2009, 28:283-286.
18. Pasqualotto A.C., Xavier M.O., Sanchez L.B., de Oliveira Costa C.D., Schio S.M., Camargo S.M., et al. Diagnosis of invasive aspergillosis in lung transplant recipients by detection of galactomannan in the bronchoalveolar lavage fluid. Transplantation 2010, 90:306-311.
19. Park S.Y., Lee S.O., Choi S.H., Sung H., Kim M.N., Choi C.M., et al. Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. J Infect 2010, 61:492-498.
20. Becker M.J., Lugtenburg E.J., Cornelissen J.J., Van Der Schee C., Hoogsteden H.C., De Marie S. Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis. Br J Haematol 2003, 121:448-457.
21. Sanguinetti M., Posteraro B., Pagano L., Pagliari G., Fianchi L., Mele L., et al. Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol 2003, 41:3922-3925.
22. Penack O., Rempf P., Graf B., Blau I.W., Thiel E. Aspergillus galactomannan testing in patients with long-term neutropenia: implications for clinical management. Ann Oncol 2008, 19:984-989.
23. Maertens J., Maertens V., Theunissen K., Meersseman W., Meersseman P., Meers S., et al. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clin Infect Dis 2009, 49:1688-1693.
24. Bergeron A., Belle A., Sulahian A., Lacroix C., Chevret S., Raffoux E., et al. Contribution of galactomannan antigen detection in BAL to the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies. Chest 2010, 137:410-415.
25. Hsu L.Y., Ding Y., Phua J., Koh L.P., Chan D.S., Khoo K.L., et al. Galactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients. BMC Infect Dis 2010, 10:44.
26. Luong M.L., Filion C., Labbe A.C., Roy J., Pepin J., Cadrin-Tourigny J., et al. Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with hematologic malignancies. Diagn Microbiol Infect Dis 2010, 68:132-139.
27. Nguyen M.H., Leather H., Clancy C.J., Cline C., Jantz M.A., Kulkarni V., et al. Galactomannan Testing in Bronchoalveolar Lavage Fluid Facilitates the Diagnosis of Invasive Pulmonary Aspergillosis in Patients with Hematologic Malignancies and Stem Cell Transplant Recipients. Biol Blood Marrow Transplnt 2010, 17:1043-1050.
28. Pfeiffer C.D., Fine J.P., Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 2006, 42:1417-1427.
29. Ascioglu S., Rex J.H., de Pauw B., Bennett J.E., Bille J., Crokaert F., et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002, 34:7-14.
30. De Pauw B., Walsh T.J., Donnelly J.P., Stevens D.A., Edwards J.E., Calandra T., et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008, 46:1813-1821.
31. Marr K.A., Balajee S.A., McLaughlin L., Tabouret M., Bentsen C., Walsh T.J. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis 2004, 190:641-649.
32. Becker M.J., de Marie S., Willemse D., Verbrugh H.A., Bakker-Woudenberg I.A. Quantitative galactomannan detection is superior to PCR in diagnosing and monitoring invasive pulmonary aspergillosis in an experimental rat model. J Clin Microbiol 2000, 38:1434-1438.
33. Vallor A.C., Kirkpatrick W.R., Najvar L.K., Bocanegra R., Kinney M.C., Fothergill A.W., et al. Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture. Antimicrob Agents Chemother 2008, 52:2593-2598.
34. Rennard S.I., Ghafouri M., Thompson A.B., Linder J., Vaughan W., Jones K., et al. Fractional processing of sequential bronchoalveolar lavage to separate bronchial and alveolar samples. Am Rev Respir Dis 1990, 141:208-217.
35. Meduri G.U., Chastre J. The standardization of bronchoscopic techniques for ventilator-associated pneumonia. Chest 1992, 102:557S-564S.
36. Cordonnier C., Botterel F., Ben Amor R., Pautas C., Maury S., Kuentz M., et al. Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis. Clin Microbiol Infect 2009, 15:81-86.
37. Stephens-Romero S.D., Mednick A.J., Feldmesser M. The pathogenesis of fatal outcome in murine pulmonary aspergillosis depends on the neutrophil depletion strategy. Infect Immun 2005, 73:114-125.
38. Balloy V., Huerre M., Latge J.P., Chignard M. Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis. Infect Immun 2005, 73:494-503.
39. Maertens J., Theunissen K., Lagrou K. Galactomannan testing. Aspergillosis: from diagnosis to prevention 2010, 1046. Springer, Dordrecht. 1st ed. A.C. Pasqualotto (Ed.).
40. Viscoli C., Machetti M., Cappellano P., Bucci B., Bruzzi P., Van Lint M.T., et al. False-positive galactomannan Platelia Aspergillus test results for patients receiving piperacillin-tazobactam. Clin Infect Dis 2004, 38:913-916.
41. Racil Z., Kocmanova I., Lengerova M., Winterova J., Mayer J. Intravenous PLASMA-LYTE as a major cause of false-positive results of Platelia Aspergillus test for galactomannan detection in serum. J Clin Microbiol 2007, 45:3141-3142.